SCHEMBL12641024

SCHEMBL12641024

COCC(COC(=O)CCc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1)(COC(=O)CCc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1)COC(=O)CCc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 7/20 0.52
KMT2A Q03164 5/20 0.49
MEN1 O00255 4/20 0.44
ALOX5 P09917 1/20 0.40
VCAM1 P19320 1/20 0.40
ALDH1A1 P00352 4/20 0.40
TSHR P16473 3/20 0.40
HTT P42858 2/20 0.40
CYP1A2 P05177 2/20 0.40
CYP3A4 P08684 2/20 0.40
MAPK1 P28482 2/20 0.40
BLM P54132 2/20 0.40
ATM Q13315 2/20 0.40
HIF1A Q16665 2/20 0.40
NPSR1 Q6W5P4 2/20 0.40
USP2 O75604 1/20 0.40
CYP2D6 P10635 1/20 0.40
MAPT P10636 1/20 0.40
PKM P14618 1/20 0.40
LMNA P02545 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23759844 1.00 GAA (0.52) GAAKMT2AMEN1ALOX5VCAM1
SCHEMBL13361942 0.95 GAA (0.48) GAAKMT2AMEN1ALOX5VCAM1
SCHEMBL30209 0.94 GAA (0.57) GAAKMT2AMEN1ALOX5VCAM1
SCHEMBL29923229 0.93 GAA (0.56) GAAKMT2AMEN1ALOX5VCAM1
SCHEMBL29764272 0.93 GAA (0.56) GAAKMT2AMEN1ALOX5VCAM1
SCHEMBL10886596 0.92 GAA (0.45) GAAKMT2AMEN1ALOX5VCAM1
SCHEMBL18901009 0.91 GAA (0.44) GAAKMT2AMEN1ALOX5VCAM1
SCHEMBL17791556 0.90 GAA (0.54) GAAKMT2AMEN1ALOX5VCAM1
SCHEMBL15700296 0.89 GAA (0.50) GAAKMT2AMEN1ALOX5VCAM1
SCHEMBL13335204 0.89 GAA (0.52) GAAKMT2AMEN1VCAM1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3924447-B1 POLYMERISABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS MERCK PATENT GMBH (DE) 2024-01-24 EP disclosed
US-11873438-B2 Liquid-crystal medium MERCK PATENT GMBH (DE) 2024-01-16 US disclosed
US-11739266-B2 Polymerisable compounds and the use thereof in liquid-crystal displays MERCK PATENT GMBH (DE) 2023-08-29 US disclosed
WO-2023158225-A1 SELF-HEALING AND RECYCLABLE POLYURETHANE POLYMER 한국화학연구원 2023-08-24 WO disclosed
US-11655417-B2 Liquid-crystal medium MERCK PATENT GMBH (DE) 2023-05-23 US disclosed
EP-3755764-B1 POLYMERISABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS MERCK PATENT GMBH (DE) 2023-05-10 EP disclosed
US-20230056437-A1 AZO DYE MERCK PATENT GMBH (DE) 2023-02-23 US disclosed
US-20230002678-A1 POLYMERISABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS MERCK PATENT GMBH (DE) 2023-01-05 US disclosed
US-11377596-B2 Liquid-crystalline media MERCK PATENT GMBH (DE) 2022-07-05 US disclosed
EP-3985085-A2 LIQUID-CRYSTAL MEDIUM Merck Patent GmbH (DE) 2022-04-20 EP disclosed
US-20180037820-A1 PIPERIDINE DERIVATIVES AND LIQUID-CRYSTALLINE MEDIUM MERCK PATENT GMBH (DE) 2018-02-08 US disclosed
EP-2909286-B1 LIQUID CRYSTALLINE MEDIUM MERCK PATENT GMBH (DE) 2017-11-22 EP disclosed
US-9822307-B2 Liquid crystalline medium and liquid crystal display MERCK PATENT GMBH (DE) 2017-11-21 US disclosed
US-9701903-B2 Liquid crystalline medium MERCK PATENT GMBH (DE) 2017-07-11 US disclosed
EP-3162875-A1 POLYMERISABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS Merck Patent GmbH (DE) 2017-05-03 EP disclosed
US-20170066966-A9 LIQUID CRYSTALLINE MEDIUM MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2017-03-09 US disclosed
EP-3127989-A1 LIQUID CRYSTALLINE MEDIUM Merck Patent GmbH (DE) 2017-02-08 EP disclosed
EP-2922933-B1 POLYMERISABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS MERCK PATENT GMBH (DE) 2017-02-01 EP disclosed
US-20110140039-A1 Liquid-crystalline medium MERCK Patent Gesellschaft mit beschränkter Haftung (DE) 2011-06-16 US disclosed
US-20110001089-A1 Liquid-crystalline medium and liquid crystal display MERCK PATENT GESELLSCHAFT (DE) 2011-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110001089-A1 Liquid-crystalline medium and liquid crystal display L1CAM, CXCR6, CHRM1 GAA 4214/4885KMT2A 4733/4885MEN1 468/4885
US-20180037820-A1 PIPERIDINE DERIVATIVES AND LIQUID-CRYSTALLINE MEDIUM NEFM, AQP1, AQP4 GAA 2128/4885KMT2A 4695/4885MEN1 2728/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.